NeoGenomics: George Cardoza, Gina Wallar

NeoGenomics has appointed George Cardoza the firm's president and chief operating officer, lab operations, effective July 5. Cardoza has been with NeoGenomics since November 2009 and served as its CFO until March 2018 when he became president of the Pharma Services Division.

Additionally, NeoGenomics appointed Gina Wallar president of the Pharma Services Division, effective July 5. She has been with the firm since December 2015 as director of the Pharma Services Division through September 2016, as SVP of sales for the division from September 2016 through May 2020, and as SVP of sales for the Clinical Services Division since then.